Navigation Links
Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90,Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory,Breast and Ovarian Cancers at ASCO

es that regulatory filings to support initiation of this clinical trial will be completed by mid-year 2007. Kosan plans to initiate a larger, international Phase 2/3 trial of alvespimycin in combination with trastuzumab in patients with HER2-positive metastatic breast cancer later in 2007.

Kosan also plans to pursue development of alvespimycin as a treatment for patients with acute myeloid leukemia (AML).

Kosan is also testing alvespimycin delivered orally in a Phase 1 dose escalation trial on both daily and every other day schedules. While dose escalation continues in this trial, early results have shown prolonged stable disease in patients with fibrosarcoma, hemangioendothelioma, melanoma and renal cell carcinoma with a favorable side effect profile.

About Kosan

Kosan Biosciences is a biotechnology company advancing two new classes of anticancer agents through clinical development -- Hsp90 (heat shock protein 90) inhibitors and epothilones. Kosan is leveraging its proprietary discovery platform to generate a pipeline of potentially significant product candidates, primarily in the area of oncology.

Hsp90 inhibitors have a novel mechanism of action targeting multiple pathways involved in cancer cell growth and survival. Kosan's proprietary formulation of tanespimycin (KOS-953) is currently in Phase 1 and 2 clinical trials, primarily for multiple myeloma in combination with Velcade(R) (bortezomib) and HER2-positive metastatic breast cancer in combination with Herceptin(R) (trastuzumab). In addition, intravenous and oral formulations of Kosan's second-generation Hsp90 inhibitor, alvespimycin (KOS-1022), are being evaluated in Phase 1 clinical trials.

Epothilones inhibit cell division with a mechanism of action similar to taxanes, one of the most successful classes of anti-tumor agents. KOS-1584 is in Phase 1 clinical trials in patients with solid tumors. Kosan's epothilone program is partnered with Roche through a global devel
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
2. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
3. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
4. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
5. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
6. Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
7. Kosan Announces Data Presentations at Upcoming AACR Annual Meeting
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
Post Your Comments:
(Date:3/30/2015)... , March 30, 2015 Perrigo Company ... provider of "Quality Affordable Healthcare Products®," today announced that ... Invest N.V. ("Omega") in a cash and equity transaction ... of €1.3 billion in debt. Sellers are Marc ... co-investors of Waterland.    "The ...
(Date:3/30/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/n6x9q9/marine ) ... Biotechnology - Global Strategic Business Report" report ... forecasts are provided for the period 2013 through ... for these markets. Market data and analytics are ... This report analyzes the worldwide markets for Marine ...
(Date:3/30/2015)... 2015 NiQ Health, "the ... the high level interface capabilities of their CarePlus™ ... The partnership between CarePlus™ and ClinicAll ... allows patients to choose the most appropriate alarm ... The advanced functionality of CarePlus™ allows patient alarms ...
Breaking Medicine Technology:Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 2Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 3Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 4Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 5Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 2Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 3Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 4Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 5Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 6Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 7NiQ Health Announces CarePlus(TM) Integration with ClinicAll 2
... (Nasdaq: ENDP ) announced today that it is ... of axomadol. Endo licensed exclusive rights to develop and market ... February 2009. "As a leader in the ... and commercialization of pain therapeutics," said Ivan Gergel, M.D., executive ...
... Endologix, Inc. (Nasdaq: ELGX ), developer and marketer ... Judge Tanya Walton Pratt of the United States District Court ... a Markman ruling in the ongoing patent infringement lawsuit filed ... a Markman ruling, the court determines the meaning of disputed ...
Cached Medicine Technology:Endo Pharmaceuticals Announces Termination of Collaboration with Grunenthal for the Development of Axomadol 2Endologix Announces Favorable Markman Ruling in Cook Patent Litigation 2
(Date:3/30/2015)... In a recent report published by ... is championing effective drug and alcohol treatment for victims ... recover funds to stabilize the addiction treatment programs, and ... drug and alcohol addiction. Harbor Village Detox is extending ... use disorders in New Jersey, in hopes to help ...
(Date:3/30/2015)... March 30, 2015 On March 29, 2015 ... Day. In honor of all small business owners, for their ... spotlighting them. , According to Zane Benefits' website, small ... economy, creating 75% of all jobs and employing over 60 ... for 54% of all U.S. sales. The small business sector ...
(Date:3/30/2015)... 2015 Follow us on LinkedIn ... develop and establish chronic pain rehabilitation centers are driving ... market is poised to benefit from the rise in ... increase in chronic health conditions such as Cancer, degenerative ... others. While conventional treatment for pain management is dominated ...
(Date:3/30/2015)... Tel-Aviv – March 30, 2015 - ... the closing of $12.5 million in new financing led ... Group. The funding will further GlassesUSA's aggressive business growth ... the growing global market of online eyewear, both B2C ... CEO Daniel Rothman, COO Eldad Rothman, and CTO Roy ...
(Date:3/30/2015)... York, New York (PRWEB) March 30, 2015 ... its Top 10 Exotic Water Awards, with the top three ... winners are listed on the company’s website, along with other ... website, exotic water, glacial water, spring water, mineral water and ... Fiji water is one of the top exotic water brands ...
Breaking Medicine News(10 mins):Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3Health News:Zane Benefits Puts Spotlight on Small Businesses for National Mom and Pop Business Owners Day 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3Health News:Best Exotic Water Brands Acclaimed by 10 Best Water 2
... who self-rated themselves as being sexually satisfied had a ... well-being" and "vitality," compared with sexually dissatisfied women in ... twice a month. The study, published today in ... a positive association between age and well-being, but a ...
... Johns Hopkins Center for a Livable Future (CLF) today ... 2009 Award for Visionary Leadership in Local Food Procurement ... groups for "outstanding contributions to advancing our understanding of ... The award was presented to Neil E. Duke, Chair ...
... Social environment can play an important role in the ... significant differences in health outcome, according to results of ... a journal of the American Association for Cancer Research. ... and shows that social isolation alters expression of genes ...
... severe and unusual shifts in mood and energy, affecting a ... in early adulthood, bipolar disorder has been thought of traditionally ... have found evidence that nearly half of those diagnosed between ... by the time they reach 30. , "Using ...
... Health Study (BWHS) of the Sloan Epidemiology Center at ... five-year continuation of grant funding award from the National ... of the largest follow-up study of the health of ... of the Slone Epidemiology Center and professor of epidemiology ...
... review past practices, researchers say , TUESDAY, Sept. ... measures used during the 1918 influenza pandemic offers lessons ... fall in response to the H1N1 swine flu pandemic, ... a common and controversial strategy for controlling the spread ...
Cached Medicine News:Health News:Sexually satisfied women have better general well-being and more vitality 2Health News:Sexually satisfied women have better general well-being and more vitality 3Health News:Lack of social interaction affects health outcomes of breast cancer 2Health News:Lack of social interaction affects health outcomes of breast cancer 3Health News:Young adults may outgrow bipolar disorder 2Health News:1918 Flu Closings May Provide Lessons for Today 2
For the qualitative detection of Wuchereria bancrofti antigen in whole blood, serum and plasma specimens...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
For the qualitative detection of luteinising Hormone (LH) in urine specimens...
Medicine Products: